‌

US Patent 11548880 Modulators of hemoglobin

Patent 11548880 was granted and assigned to Global Blood Therapeutics on January, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Current Assignee

Global Blood Therapeutics

Date Filed

May 4, 2020

Date of Patent

January 10, 2023

Patent Applicant

Global Blood Therapeutics

Patent Application Number

16865625

Patent Citations

‌

US Patent 10100043 Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation

‌

US Patent 10137118 Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde

‌

US Patent 10266551 Compounds and uses thereof for the modulation of hemoglobin

‌

US Patent 10315991 Compounds and uses thereof for the modulation of hemoglobin

‌

US Patent 10377741 Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation

‌

US Patent 10435393 Compounds and uses thereof for the modulation of hemoglobin

‌

US Patent 10450269 Compounds and uses thereof for the modulation of hemoglobin

‌

US Patent 10683285 Modulators of hemoglobin

‌

US Patent 10493035 Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde

‌

US Patent 10004725 Methods of treatment

•••

Patent Citations Received

‌

US Patent 11939323 Methods of making a modulator of hemoglobin

‌

US Patent 11851424 Solid forms of a modulator of hemoglobin

Patent Inventor Names

Zhe Li

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11548880

Patent Primary Examiner

CPC Code

Find more entities like US Patent 11548880 Modulators of hemoglobin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.